Metrics Appoints New Vice-President - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Metrics Appoints New Vice-President


PTSM: Pharmaceutical Technology Sourcing and Management
Volume 10, Issue 1

Metrics has appointed John Ross as executive vice-president. In his new role, Ross is responsible for managing and expanding Metrics’ fee-for-service operations. The company’s contract services include pharmaceutical oral dose formulation development with suites for potent-product handling, clinical trial materials manufacturing, analytical testing method development and validation, stability studies, and other laboratory support services.

Ross’s 20 years of managerial experience include serving as COO and leading US and Canadian operations at CPL, a contract manufacturing organization for liquid and semisolid pharmaceutical products headquartered in Canada.

Source: Metrics

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
24%
Attracting a skilled workforce
30%
Obtaining/maintaining adequate financing
15%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
Source: PTSM: Pharmaceutical Technology Sourcing and Management,
Click here